What is the ICD10 code for a patient on antiviral (antiviral medication) prophylaxis for Human Immunodeficiency Virus (HIV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code for HIV Prophylaxis

The ICD-10 code for a patient on antiviral prophylaxis for HIV is Z20.6 (Contact with and [suspected] exposure to human immunodeficiency virus [HIV]).

Primary Coding for HIV Prophylaxis

  • Z20.6 is the appropriate code when documenting a patient receiving antiretroviral prophylaxis following potential HIV exposure or for ongoing prevention in high-risk individuals 1.

  • This code applies to both post-exposure prophylaxis (PEP) scenarios where antiretroviral therapy is initiated within 72 hours of exposure and continued for 28 days, and pre-exposure prophylaxis (PrEP) where patients at ongoing risk take daily antiretroviral medication 1.

Additional Relevant Codes

  • Z79.899 (Other long-term [current] drug therapy) may be used as a secondary code to indicate the patient is on chronic antiretroviral medication, particularly for PrEP users on daily tenofovir disoproxil fumarate/emtricitabine 2, 3.

  • Z11.4 (Encounter for screening for human immunodeficiency virus [HIV]) should be used for the mandatory quarterly HIV testing required during PrEP monitoring 2, 3.

Clinical Context for Coding

  • For PrEP patients, the coding reflects ongoing prophylaxis with daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), which requires HIV testing every 3 months, STI screening, and creatinine monitoring 2, 3.

  • For PEP patients, the coding applies during the 28-day treatment course following exposure, with preferred regimens including bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir plus two nucleoside reverse transcriptase inhibitors 1.

  • The code Z20.6 is appropriate regardless of whether the exposure was sexual, injection drug use-related, or other nonoccupational exposure 1.

Important Coding Caveats

  • Do not use Z20.6 if the patient has confirmed HIV infection; use B20 (Human immunodeficiency virus [HIV] disease) instead 1.

  • If PrEP is inadvertently prescribed to someone with undiagnosed acute HIV infection (which can occur with false-negative antibody/antigen testing within 7-10 days of infection), the coding should shift to B20 once diagnosis is confirmed 4.

  • For pediatric patients receiving prophylaxis, the same Z20.6 code applies, though specific antiretroviral regimens differ by age and weight 1, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guidelines for HIV Pre-Exposure Prophylaxis in Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tenofovir Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is PrEP with Truvada (emtricitabine/tenofovir disoproxil fumarate) or Descovy (emtricitabine/tenofovir alafenamide) indicated for a patient at risk of HIV?
What is the recommended frequency for Human Immunodeficiency Virus (HIV) testing in high-risk populations, such as homosexual men?
What is the best recommendation to reduce the risk of infectious disease transmission in a patient who injects fentanyl daily, shares equipment with a partner, and has a negative HIV (Human Immunodeficiency Virus) status, normal renal function, and positive antibodies for hepatitis A and B, but negative for hepatitis C?
Can Acriptega (generic name unknown) be used as pre-exposure prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) infection?
What is the best Pre-Exposure Prophylaxis (PrEP) regimen to recommend for a patient with a history of injection drug use and high risk of acquiring Human Immunodeficiency Virus (HIV)?
What dose of intravenous (IV) morphine is necessary to compensate for a depleted morphine pump that was delivering 52 micrograms (mcg) per day?
What is the management plan for an 82-year-old patient with a Hemoglobin A1c (HbA1c) level of 6.7%?
How long do opiates (opioid analgesics) remain detectable in urine?
What is the initial treatment for acromegaly?
What is the recommended bicarbonate dosing for patients with Chronic Kidney Disease (CKD) and metabolic acidosis?
Can Lasix (furosemide) be used to manage fluid overload in patients with congestive heart failure (CHF) and hyperglycemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.